Compagnie Lombard Odier SCmA’s VanEck Biotech ETF BBH Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-750	Closed	-$120K	–	601
2023 Q1	$121K	Buy	+750	New	+$121K	﹤0.01%	357
2016 Q4	–	Sell	-800	Closed	-$92K	–	815
2016 Q3	$92K	Hold	800	–	–	﹤0.01%	584
2016 Q2	$82K	Hold	800	–	–	﹤0.01%	596
2016 Q1	$83K	Hold	800	–	–	﹤0.01%	649
2015 Q4	$101K	Hold	800	–	–	﹤0.01%	593
2015 Q3	$91K	Hold	800	–	–	﹤0.01%	530
2015 Q2	$108K	Hold	800	–	–	﹤0.01%	543
2015 Q1	$104K	Buy	+800	New	+$101K	﹤0.01%	649

Other funds holding BBH

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Compagnie Lombard Odier SCmA's BBH Position: Q2 2023 in Review

Compagnie Lombard Odier SCmA sold out of VanEck Biotech ETF (BBH) in Q2 2023, closing a stake of 750 shares — an estimated $120K sold.

Compagnie Lombard Odier SCmA first reported a position in BBH in Q1 2015 and held it in 8 quarters. The position peaked at $121K in Q1 2023. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2023.

Compagnie Lombard Odier SCmA reported no remaining VanEck Biotech ETF position as of Q2 2023 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 750 VanEck Biotech ETF shares in Q2 2023, an estimated $120K.
Compagnie Lombard Odier SCmA first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 8 quarters.
Compagnie Lombard Odier SCmA's VanEck Biotech ETF position peaked at $121K in Q1 2023.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2023, filed 7 Aug 2023.